Drugs / RO6807952
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01358929 | Apr → Sep 2011 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01516476 | Nov 2011 → Jan 2012 | type 2 diabetes mellitus | Hoffmann-La Roche | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO6807952 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01358929 ↗ |
| Route | Subcutaneous | “multiple weekly subcutaneous doses” NCT01358929 ↗ |